BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23660013)

  • 1. Assay for peptidoglycan O-acetyltransferase: a potential new antibacterial target.
    Moynihan PJ; Clarke AJ
    Anal Biochem; 2013 Aug; 439(2):73-9. PubMed ID: 23660013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity and kinetic characterization of peptidoglycan O-acetyltransferase B from Neisseria gonorrhoeae.
    Moynihan PJ; Clarke AJ
    J Biol Chem; 2014 Jun; 289(24):16748-60. PubMed ID: 24795044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a new family of enzymes with potential O-acetylpeptidoglycan esterase activity in both Gram-positive and Gram-negative bacteria.
    Weadge JT; Pfeffer JM; Clarke AJ
    BMC Microbiol; 2005 Aug; 5():49. PubMed ID: 16111493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of O-acetylpeptidoglycan esterase: a novel enzyme discovered in Neisseria gonorrhoeae.
    Weadge JT; Clarke AJ
    Biochemistry; 2006 Jan; 45(3):839-51. PubMed ID: 16411760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of peptidoglycan O-acetyltransferase B involves a Ser-His-Asp catalytic triad.
    Moynihan PJ; Clarke AJ
    Biochemistry; 2014 Oct; 53(39):6243-51. PubMed ID: 25215566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the first known inhibitors of O-acetylpeptidoglycan esterase: a potential new antibacterial target.
    Pfeffer JM; Clarke AJ
    Chembiochem; 2012 Mar; 13(5):722-31. PubMed ID: 22351512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water-soluble substrates of the peptidoglycan-modifying enzyme O-acetylpeptidoglycan esterase (Ape1) from Neisseria gonorrheae.
    Hadi T; Pfeffer JM; Clarke AJ; Tanner ME
    J Org Chem; 2011 Feb; 76(4):1118-25. PubMed ID: 21244065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of Peptidoglycan O-Acetylation Leads to Altered Cell Wall Biochemistry and Negatively Impacts Pathogenesis Factors of Campylobacter jejuni.
    Ha R; Frirdich E; Sychantha D; Biboy J; Taveirne ME; Johnson JG; DiRita VJ; Vollmer W; Clarke AJ; Gaynor EC
    J Biol Chem; 2016 Oct; 291(43):22686-22702. PubMed ID: 27474744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidoglycan Acetylation of Campylobacter jejuni Is Essential for Maintaining Cell Wall Integrity and Colonization in Chicken Intestines.
    Iwata T; Watanabe A; Kusumoto M; Akiba M
    Appl Environ Microbiol; 2016 Oct; 82(20):6284-6290. PubMed ID: 27520822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-acetylation of peptidoglycan in gram-negative bacteria: identification and characterization of peptidoglycan O-acetyltransferase in Neisseria gonorrhoeae.
    Moynihan PJ; Clarke AJ
    J Biol Chem; 2010 Apr; 285(17):13264-73. PubMed ID: 20178982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus.
    Bera A; Herbert S; Jakob A; Vollmer W; Götz F
    Mol Microbiol; 2005 Feb; 55(3):778-87. PubMed ID: 15661003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De-O-acetylation of peptidoglycan regulates glycan chain extension and affects in vivo survival of Neisseria meningitidis.
    Veyrier FJ; Williams AH; Mesnage S; Schmitt C; Taha MK; Boneca IG
    Mol Microbiol; 2013 Mar; 87(5):1100-12. PubMed ID: 23373517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a High Throughput Screen for the Identification of Inhibitors of Peptidoglycan
    Brott AS; Jones CS; Clarke AJ
    Antibiotics (Basel); 2019 May; 8(2):. PubMed ID: 31137799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori peptidoglycan modifications confer lysozyme resistance and contribute to survival in the host.
    Wang G; Lo LF; Forsberg LS; Maier RJ
    mBio; 2012 Dec; 3(6):e00409-12. PubMed ID: 23221800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro characterization of the antivirulence target of Gram-positive pathogens, peptidoglycan O-acetyltransferase A (OatA).
    Sychantha D; Jones CS; Little DJ; Moynihan PJ; Robinson H; Galley NF; Roper DI; Dowson CG; Howell PL; Clarke AJ
    PLoS Pathog; 2017 Oct; 13(10):e1006667. PubMed ID: 29077761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neisseria gonorrheae O-acetylpeptidoglycan esterase, a serine esterase with a Ser-His-Asp catalytic triad.
    Weadge JT; Clarke AJ
    Biochemistry; 2007 Apr; 46(16):4932-41. PubMed ID: 17388571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Structure-Function Relationship of Lysozyme Resistance in Staphylococcus aureus by Peptidoglycan O-Acetylation Using Molecular Docking, Dynamics, and Lysis Assay.
    Pushkaran AC; Nataraj N; Nair N; Götz F; Biswas R; Mohan CG
    J Chem Inf Model; 2015 Apr; 55(4):760-70. PubMed ID: 25774564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assays for the Enzymes Catalyzing the O-Acetylation of Bacterial Cell Wall Polysaccharides.
    Brott AS; Sychantha D; Clarke AJ
    Methods Mol Biol; 2019; 1954():115-136. PubMed ID: 30864128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity.
    Bera A; Biswas R; Herbert S; Götz F
    Infect Immun; 2006 Aug; 74(8):4598-604. PubMed ID: 16861647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-Acetylated peptidoglycan: controlling the activity of bacterial autolysins and lytic enzymes of innate immune systems.
    Moynihan PJ; Clarke AJ
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1655-9. PubMed ID: 21889603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.